|
|
 |
|
Viewing report
|
|
|
|
Commercial Insight: Hormonal Contraceptives - Look Beyond Oral Contraception for a Competitive Edge
Datamonitor, Oct 2009, Pages: 243
Since the 1960s, hormonal contraceptives have been widely used as effective birth control in the developed world. Although they are mainly used to prevent pregnancies, they can be used for treating other conditions such as acne, endometriosis, and polycystic ovarian syndrome. In 2008, the hormonal contraceptives market was worth $6.2 billion across the seven major pharmaceutical countries.
Scope
- Analysis of the global hormonal contraceptive prescriptions from 200408, split by geographical region, drug class, indication, and brand.
- Discussion of key commercial opportunities and threats in the US, Japan, and five major European markets.
- In depth profiles of key current hormonal contraceptive brands and pipeline agents with SWOT analyses and country-specific sales forecasts to 2018.
- Detailed analysis of key developer trends, strategies and portfolios including a case study of Bayer-Schering's Yasmin franchise.
Highlights of this title
Sales of hormonal contraceptives in the seven major markets accounted for 68% of the global market value. Over the forecast period 20092018, the market is expected to grow due to the launch of novel natural estrogen products, which will be well received in the US in particular, and the launch of new prescription emergency contraceptives in the EU.
The market offers opportunities for current and future market players. In addition to indication expansions, there is the need to develop delivery mechanisms that will increase compliance and efficacy. However, the current market environment poses several threats to market growth such as the high litigation pressure and the need to cut sales forces
Marketing is a key tool for companies in this market to increase sales of their brands. Datamonitor recommends that companies should also focus on marketing the secondary benefits of taking hormonal contraceptives, such as the decreased risk of gynecological cancers, to increase acceptance of contraceptives.
Key reasons to purchase this title
- Understand historical (200408) and future (20092018) hormonal contraceptive drug market dynamics and competitive environment.
- Gain insight into the main opportunities and threats specific to the hormonal contraceptive market.
- Evaluate the sales forecasts of marketed, generic, and key pipeline drugs to 2018 in the US, Japan, France, Germany, Italy, Spain, and the UK.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Hormonal Contraceptives Market Forecast
Strategic Perspectives 2001: Hormonal contraceptives
Stakeholder Opinions: Hormonal Contraceptives - New directions in a competitive market
The Global Market For Hormonal Contraceptives and Infertility Drugs, 2005-2012
Hormonal Contraception: Market Update - Surviving the Generic Threat
Contraceptives - Global Strategic Business Report
Oral Contraceptives & Condom Market: An Analysis
World Contraceptive and Infertility Drug Markets
Women's Health Series: How Have New Oral Contraceptives Changed the Market?
The 2009-2014 Outlook for Non-Hormonal Anti-Arthritics and Anti-Inflammatory Agents in Japan
The 2009-2014 Outlook for Non-Hormonal Anti-Arthritics and Anti-Inflammatory Agents in India
The 2009 Report on Non-Hormonal Anti-Arthritics and Anti-Inflammatory Agents: World Market Segmentation by City
|
|
|
|
